Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot multicenter randomized double-blind study of botulinum toxin in vestibulodynia
2009-016513-26Phase 3Completed
- Sponsor
- CHU de Besançon
- Start
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vestibulodynia comparing Botulinum toxin type A with Placebo (2 arms). Started Oct 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
vestibulodynia
Beyond the preview
Go deeper on 2009-016513-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016513-26.